Characterizing Mycobacterium tuberculosis isolates from Karachi, Pakistan: Drug resistance and genotypes

International Journal of Infectious Diseases

Volumn 16, Issue 4, 2012, Pages

  Ayaz, Afsheen ^a   Hasan, Zahra ^a   Jafri, Sana ^a   Inayat, Raunaq ^a   Mangi, Rafique ^b   Channa, Abid Ali ^b   Malik, Faisal Riaz ^a   Ali, Asho ^a   Rafiq, Yasraba ^a   Hasan, Rumina ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

^b Marie Adelaide Leprosy Centre   (Pakistan)

Author keywords

Cross sectional study; Drug resistant tuberculosis; Isoniazid; MIRU VNTR; Mycobacterium tuberculosis; Rifampin; Spoligotyping

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CHILD; CROSS-SECTIONAL STUDY; DRUG SENSITIVITY; ETHNICITY; FEMALE; GENOTYPE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PAKISTAN; RISK FACTOR; SCHOOL CHILD; SOCIAL STATUS;

ADOLESCENT; ADULT; CHILD; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MOLECULAR TYPING; MYCOBACTERIUM TUBERCULOSIS; PAKISTAN; PREVALENCE; RISK FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84858293840     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2011.12.015     Document Type: Article

References (26)

1. Gandhi N.R., Nunn P., Dheda K., Schaaf H.S., Zignol M., van Soolingen D., et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 2010, 375:1830-1843.
2. World Health Organization. Global tuberculosis control: surveillance, planning, financing: WHO report 2008. WHO/HTM/TB/2008393. Geneva, Switzerland: WHO; 2008.
3. World Health Organization. Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. WHO/HTM/TB/20103. Geneva, Switzerland: WHO; 2008.
4. World Health Organization. Global tuberculosis control: epidemiology, strategy, financing. WHO report 2009. WHO/HTM/TB/2009411. Geneva, Switzerland: WHO; 2009.
5. Javaid A., Hasan R., Zafar A., Ghafoor A., Pathan A.J., Rab A., et al. Prevalence of primary multidrug resistance to anti-tuberculosis drugs in Pakistan. Int J Tuberc Lung Dis 2008, 12:326-331.
6. World Health Organization. Anti-tuberculosis drug resistance in the world. Report No. 4. Geneva, Switzerland: WHO; 2008.
7. Ramachandran R., Nalini S., Chandrasekar V., Dave P.V., Sanghvi A.S., Wares F., et al. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India. Int J Tuberc Lung Dis 2009, 13:1154-1160.
8. Storla D.G., Rahim Z., Islam M.A., Plettner S., Begum V., Myrvang B., et al. Drug resistance of Mycobacterium tuberculosis in the Sunamganj District of Bangladesh. Scand J Infect Dis 2007, 39:142-145.
9. World Health Organization. Treatment of tuberculosis: guidelines. Fourth edition. WHO/HTM/TB/2009420. Geneva, Switzerland: WHO; 2009.
10. Pakistan Chest Society. Guidelines for diagnosis and management of tuberculosis: a national clinical guideline. Pakistan Chest Society; 2011.
11. Malakmadze N., Gonzalez I.M., Oemig T., Isiadinso I., Rembert D., McCauley M.M., et al. Unsuspected recent transmission of tuberculosis among high-risk groups: implications of universal tuberculosis genotyping in its detection. Clin Infect Dis 2005, 40:366-373.
12. Tanveer M., Hasan Z., Siddiqui A.R., Ali A., Kanji A., Ghebremicheal S., et al. Genotyping and drug resistance patterns of M. tuberculosis strains in Pakistan. BMC Infect Dis 2008, 8:171.
13. Hasan Z., Tanveer M., Kanji A., Hasan Q., Ghebremichael S., Hasan R. Spoligotyping of Mycobacterium tuberculosis isolates from Pakistan reveals predominance of Central Asian strain 1 and Beijing isolates. J Clin Microbiol 2006, 44:1763-1768.
14. Shakoor S., Tanveer M., Rafiq Y., Hasan Z., Javed A., Rizvi N., et al. Prevalence of ST26 among untreated smear-positive tuberculosis patients from Karachi indicating ongoing transmission. Scand J Infect Dis 2009, 41:714-719.
15. Ejaz M., Siddiqui A.R., Rafiq Y., Malik F., Channa A., Mangi R., et al. Prevalence of multi-drug resistant tuberculosis in Karachi, Pakistan: identification of at risk groups. Trans R Soc Trop Med Hyg 2010, 104:511-517.
16. City District Government Karachi. Official web portal of the City District Government Karachi. Available at: (accessed December 8, 2011). http://www.karachicity.gov.pk/.
17. Kamerbeek J., Schouls L., Kolk A., van Agterveld M., van Soolingen D., Kuijper S., et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 1997, 35:907-914.
18. Brudey K., Driscoll J.R., Rigouts L., Prodinger W.M., Gori A., Al-Hajoj S.A., et al. Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol 2006, 6:23.
19. Supply P., Allix C., Lesjean S., Cardoso-Oelemann M., Rusch-Gerdes S., Willery E., et al. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol 2006, 44:4498-4510.
20. World Health Organization; Stop TB Department. Roadmap for rolling out Xpert MTB/RIF for rapid diagnosis of TB and MDR TB. Geneva, Switzerland: WHO; December 2010.
21. Walls T., Shingadia D. Global epidemiology of paediatric tuberculosis. J Infect 2004, 48:13-22.
22. Shao Y., Yang D., Xu W., Lu W., Song H., Dai Y., et al. Epidemiology of anti-tuberculosis drug resistance in a Chinese population: current situation and challenges ahead. BMC Public Health 2011, 11:110.
23. Banu S., Hossain A., Uddin M.K., Uddin M.R., Ahmed T., Khatun R., et al. Pulmonary tuberculosis and drug resistance in Dhaka central jail, the largest prison in Bangladesh. PLoS One 2010, 5:e10759.
24. Pablos-Mendez A., Raviglione M.C., Laszlo A., Binkin N., Rieder H.L., Bustreo F., et al. Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 1998, 338:1641-1649.
25. World Health Organization. Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. Geneva, Switzerland: WHO; 2010.
26. Farnia P., Masjedi M.R., Mirsaeidi M., Mohammadi F., Jallaledin G., Vincent V., et al. Prevalence of Haarlem I and Beijing types of Mycobacterium tuberculosis strains in Iranian and Afghan MDR-TB patients. J Infect 2006, 53:331-336.